Implementing National Rare Disease Plans: how to streamline pricing and reimbursement processes?

In Advocacy, Market Access by Freya SmaleLeave a Comment

Ségolène Aymé, INSERM presents ‘Implementing National RD Plans: Streamlining National Processes for Pricing and Reimbursement Decisions.’

Download this presentation now to find out more about:

  • Effect at national level National plans/strategies
  • Content of Belgium National Plan in relation to pricing and reimbursement
  • Content of French National Plan in relation to pricing and reimbursement
  • Content of German National Plan in relation to pricing and reimbursement
  • Registries as strategic tools
  • EU Policy for Orphan Drugs

…And much more!

Get your copy here!

If you are interested in finding out more about pricing and reimbursement, then join us at the 5th Annual World Orphan Drug Congress Europe.

Orphan EU banner

 

Leave a Comment